Vimian Group ABVIMGF 76 Days Inventory is 220.84 as of Mar. 2026, which is 6% above its 10-year median of 207.61. GuruFocus rates VIMGF with a GF Score™ of 76/100 and a GF Value™ of $3.26. The stock has 2 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, Vimian Group AB ranks worse than 85.8% on this metric.
The historical rank and industry rank for Vimian Group AB's Days Inventory or its related term are showing as below:
VIMGF'
s Days Inventory Range Over the Past 10 Years
Min: 122.17 Med: 207.61 Max: 225.12
Current: 221.18
During the past 9 years, Vimian Group AB's highest Days Inventory was 225.12. The lowest was 122.17. And the median was 207.61.
VIMGF's Days Inventory is ranked worse than 85.8% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 68.88
vs VIMGF: 221.18
Vimian Group AB's Days Inventory
increased
from Mar. 2025 (215.06) to Mar. 2026 (220.84).
It might indicate that Vimian Group AB's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vimian Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.41.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vimian Group AB's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Vimian Group AB (OTCPK:VIMGF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vimian Group AB's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vimian Group AB's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vimian Group AB Days Inventory Related Terms
Vimian Group AB Days Inventory Historical Data
* Premium members only.
The historical data trend for Vimian Group AB's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VIMGF vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Vimian Group AB's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vimian Group AB Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Vimian Group AB's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vimian Group AB's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vimian Group AB (VIMGF) has a Days Inventory of 220.84 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vimian Group AB and its competitors. This is near median its historical median of 207.61. Over the past decade, Vimian Group AB's Days Inventory has ranged from 122.17 to 225.12. According to the industry distribution chart, Vimian Group AB ranks #151 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 85.8%.
Is Vimian Group AB's Days Inventory too high?
Vimian Group AB's current Days Inventory of 220.84 is near median its 10-year median of 207.61. Over the past 10 years, this metric has ranged from a low of 122.17 to a high of 225.12. The Medical Diagnostics & Research industry median Days Inventory is 68.88. Vimian Group AB's value of 220.84 is 220.6% above this industry median. Based on the distribution chart, Vimian Group AB ranks #151 out of 176 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Vimian Group AB has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Vimian Group AB's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Vimian Group AB ranks #151 out of 176 companies for Days Inventory. This places Vimian Group AB in the lower half of its industry. The industry median Days Inventory is 68.88. Vimian Group AB's value of 220.84 is 220.6% above this benchmark. Historically, Vimian Group AB's own Days Inventory has ranged from 122.17 to 225.12 over the past decade. While the company's 10-year median is 207.61 vs. the industry median of 68.88, Vimian Group AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 68.88, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vimian Group AB's current Days Inventory of 220.84 is 220.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Vimian Group AB and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 68.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vimian Group AB's current Days Inventory is 220.84, which is near median its own 10-year median of 207.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimian Group AB stock overvalued right now?
Vimian Group AB (VIMGF) has a current Days Inventory of 220.84. The stock's GF Value™ is $3.26, compared to a current price of $2.77 — trading 15% below its estimated fair value. The current Days Inventory is 220.84, which is near median its 10-year median of 207.61 and 220.6% above the Medical Diagnostics & Research industry median of 68.88. Vimian Group AB's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Vimian Group AB (VIMGF), the current Days Inventory is 220.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vimian Group AB (VIMGF) Overvalued in 2026?
Based on GuruFocus' analysis, Vimian Group AB stock appears to be undervalued.
The current stock price of $2.77 is trading 15% below its estimated GF Value™ of $3.26.
Key valuation signals for VIMGF:
Days Inventory: 220.84 (near median its 10-year median of 207.61)
GF Value™: $3.26 vs. price of $2.77 (15% below fair value)
Industry Position: 220.6% above the Medical Diagnostics & Research median (#151 of 176)
No single metric tells the full story. See the VIMGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
76GF Score
Get the complete analysis for VIMGF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VIMGF has been successfully added to your 
